Clark IAN T
SEC-identified person · CIK 1336504 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Olema Pharmaceuticals, Inc. OLMA | Director | filed 2020 - 2026 |
| Guardant Health, Inc. GH | Director | filed 2018 - 2026 |
| Corvus Pharmaceuticals, Inc. CRVS | Director | filed 2017 - 2026 |
| Biomarin Pharmaceutical INC BMRN | Director | filed 2025 - 2026 |
| Kyverna Therapeutics, Inc. KYTX | Director | filed 2024 - 2026 |
| Takeda Pharmaceutical CO LTD TAK | Director | filed 2026 - 2026 |
| Goodrx Holdings, Inc. GDRX | Director | filed 2024 - 2025 |
| Tectonic Therapeutic, Inc. TECX | Director | filed 2018 - 2023 |
| Agios Pharmaceuticals, INC. AGIO | Director | filed 2017 - 2022 |
| Forty Seven, Inc. FTSV | Director | filed 2018 - 2020 |
| Kite Pharma, Inc. KITE | Director | filed 2017 - 2017 |
| Terravia Holdings, Inc. TVIA | Director | filed 2011 - 2017 |
| Dendreon Corp DNDNQ | Director · Board of Director | filed 2009 - 2010 |
| Genentech INC DNA | EVP-COMMERCIAL OPERATIONS | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.